|
Volumn 15, Issue 4, 2002, Pages 434-440
|
Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas
|
Author keywords
Kaposi's sarcoma; Lymphatic endothelium; Monoclonal antibody; Vascular lesions
|
Indexed keywords
CD31 ANTIGEN;
FORMALDEHYDE;
IMMUNOGLOBULIN G1;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY D2 40;
PARAFFIN;
UNCLASSIFIED DRUG;
ANGIOLIPOMA;
ANGIOSARCOMA;
ARTICLE;
CELL DIFFERENTIATION;
CONGENITAL BLOOD VESSEL MALFORMATION;
CONTROLLED STUDY;
DISEASE MARKER;
GLOMUS TUMOR;
HEMANGIOENDOTHELIOMA;
HEMANGIOMA;
HEMANGIOPERICYTOMA;
HISTOGENESIS;
HUMAN;
HUMAN TISSUE;
IMMUNOREACTIVITY;
KAPOSI SARCOMA;
LYMPH VESSEL;
LYMPH VESSEL ENDOTHELIUM;
LYMPHANGIOMA;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PYOGENIC GRANULOMA;
ANTIBODIES, MONOCLONAL;
ANTIBODY SPECIFICITY;
ANTIGENS, CD31;
BIOLOGICAL MARKERS;
ENDOTHELIUM, LYMPHATIC;
HEMANGIOSARCOMA;
HUMANS;
IMMUNOHISTOCHEMISTRY;
SARCOMA, KAPOSI;
|
EID: 0036227312
PISSN: 08933952
EISSN: None
Source Type: Journal
DOI: 10.1038/modpathol.3880543 Document Type: Article |
Times cited : (547)
|
References (23)
|